Location History:
- Library, PA (US) (1996 - 2002)
- Galloway, OH (US) (2001 - 2014)
- Dublin, OH (US) (2020)
Company Filing History:
11 out of 70 
2 out of 827 
1 out of 62 
Years Active: 1996-2020
Title: Pui-Kai Li: A Pioneer in Innovation and Patents
Introduction:
Pui-Kai Li, a renowned innovator in the field of technology, has made significant contributions throughout his career. From his extensive patent portfolio to his prestigious positions in leading companies, Li has established himself as a key figure in the world of innovation. This article delves into his latest patents, career highlights, collaborations, and his overall impact on the field.
Latest Patents:
Li's creative endeavors have led to the development of numerous groundbreaking patents. Two of his recent patents include:
1. Pyrrolopyrimidine derivatives as Mps1/TTK kinase inhibitors:
This patent discloses novel compounds that act as Mps1/TTK kinase inhibitors, showcasing potential application in treating various diseases. Coupled with this invention, Li has demonstrated his commitment to finding innovative solutions in the field of healthcare.
2. Transcription factor inhibitors and related compositions, formulations and methods:
Recognizing the potential of small molecules in cancer therapy, Li's patent presents compounds that selectively affect cancer cells. This research provides a foundation for further exploration and development of treatments related to cancer research and therapeutic advancements.
Career Highlights:
Having held key positions in esteemed technology companies, Pui-Kai Li's career is studded with notable accomplishments. A few highlights include:
1. Duquesne University of the Holy Ghost:
During his tenure at the Duquesne University of the Holy Ghost, Li contributed significantly to the institution's research and development initiatives. His role enabled collaborations and advancements across various technological domains.
2. IBM (International Business Machines Corporation):
Li's stint at IBM further cemented his reputation as an influential innovator. As one of the world's leading technology companies, IBM provided Li with a platform to explore cutting-edge research and collaborate with exceptional minds in the industry.
Collaborations:
Li's dedication to innovation extends beyond individual achievements. Collaborating with esteemed professionals in the field has enriched his contributions. Notable collaborations include:
1. Kyle W Selcer:
Working alongside Kyle W Selcer, Li has devised strategies and developed technologies that have pushed the boundaries of innovation. This fruitful partnership has resulted in joint patents and advancements in various fields of study.
2. Chikara Murakata:
Collaborating with Chikara Murakata, Li has achieved synergy in their research endeavors. Together, they have explored new avenues in cancer therapeutics, adding value to their respective fields and benefiting the larger scientific community.
Conclusion:
Pui-Kai Li's journey through the world of innovation and patents showcases a career rich in research and pioneering developments. From his extensive patent portfolio to his impactful collaborations, Li has continually pushed the boundaries of technological advancement. His contributions in the field of healthcare and cancer research highlight his commitment to improving lives through groundbreaking inventions. As we eagerly anticipate what lies ahead for this visionary innovator, we can only imagine the transformative impact his future endeavors will bring.